Evidence map›Paper›PMID 29297178›Full record

Trial reportCardiology journal2019

OCULUS study: Virtual reality-based education in daily clinical practice.

Paweł Balsam, Sonia Borodzicz, Karolina Malesa, Dominika Puchta, Agata Tymińska, Krzysztof Ozierański, Łukasz Kołtowski, Michał Peller, Marcin Grabowski, Krzysztof J Filipiak and 1 more

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Cardiology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03104231 (OCULUS), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03104231 nacompletednot on this map

OCULUS: a 3-D Movie to Improve Patient Compliance

TypeinterventionalSponsorMedical University of WarsawRan2016 to 2017Enrolled100ConditionsmHealthArmsthree-dimensional (3D) movie
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Extended reality in cardiovascular care: a systematic review.European heart journal. Digital health · 2025
    Review
  4. Article
  5. Virtual Reality for Patient Education about Hypertension: A Randomized Pilot Study.Journal of cardiovascular development and disease · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Paweł BalsamFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Sonia BorodziczFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland. sonia.borodzicz@onet.pl.
Karolina MalesaFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Dominika PuchtaFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Agata TymińskaFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Krzysztof OzierańskiFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Łukasz KołtowskiFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Michał PellerFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Marcin GrabowskiFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Krzysztof J FilipiakFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Grzegorz OpolskiFirst Chair and Department of Cardiology, Medical University of Warsaw, Poland.
Medical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) is associated with high risk of stroke and other thromboembolic complications. The OCULUS study aimed to evaluate the effectiveness of the three-dimensional (3D) movie in teaching patients about the consequences of AF and pharmacological stroke prevention.

methodsThe study was based on a questionnaire and included 100 consecutive patients (38% women, 62% with AF history). Using the oculus glasses and a smartphone, a 3D movie describing the risk of stroke in AF was shown. Similar questions were asked immediately after, 1 week and 1 year after the projection.

resultsBefore the projection 22/100 (22.0%) declared stroke a consequence of AF, while immediately after 83/100 (83.0%) (p < 0.0001) patients declared this consequence. Seven days after, stroke as AF consequence was chosen by 74/94 (78.7%) vs. 22/94 (23.4%) when compared to the baseline knowledge; p < 0.0001, a similar trend was also observed in 1-year follow-up (64/90 [71.1%] vs. 21/90 [23.3%]; p < 0.0001). Before the projection 88.3% (83/94) patients responded, that drugs may reduce the risk of stroke, and after 1 week the number of patients increased to (94/94 [100%]; p = 0.001). After 1 year 87/90 (96.7%) answered that drugs may diminish the risk of stroke (p = 0.02 in comparison to the baseline survey 78/90 [86.7%]). Use of oral anticoagulation to reduce the risk of stroke was initially chosen by 66/94 (70.2%), by 90/94 (95.7%; p < 0.0001) 7 days after and by 83/90 (92.2%; p < 0.0001) 1 year after.

conclusions3D movie is an effective tool in transferring knowledge about the consequences of AF and the pivotal role of oral anticoagulation in stroke prevention.

trial registrationClinicalTrials.gov, NCT03104231. Registered on 28 March 2017.

Indexed as

Mobile ApplicationsSmart GlassesSmartphoneVirtual RealityAdministration, OralAgedAnticoagulantsAtrial FibrillationFemaleHealth Knowledge, Attitudes, PracticeHealth LiteracyHumansMaleMiddle AgedPatient Education as TopicProspective StudiesAnticoagulantsatrial fibrillationeducationstrokethree-dimensional movievirtual reality

Identifiers

PMID29297178
PMCPMC8086674
OpenAlexW2781850304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.